Health Care · Pharmaceutical Preparations · Nasdaq · CIK 1736243 · FYE Dec 31 · Prices AT CLOSE 2026-07-28 (USD) — end-of-day, never a live or intraday quote
Last $1.41Day −1.40%Mkt cap $6M1Y −82.7%Off 52W high −83.7%Vol (1Y) 187.9%
Daily closing price, split-adjusted to the current basis; 3y shown of 943 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest2.4% of sh out |
| Days to cover1.0d |
| 13F net flow (QoQ)+1.27% |
| Top-10 13F concentration96.8% |
| Next report (est.)2026-08-12 |
Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| Earnings (TTM)-$7.5M |
| ROE−270.8% |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (USD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD−43.4% |
| 1Y−82.7% |
| 3Y−96.3% |
| Since incept. (ann.)−62.8% |
Total return through 2026-07-28 · series begins 2022-10-18. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)187.9% |
| Ann. volatility (3Y)171.2% |
| Sharpe (1Y)−0.25 |
| Sharpe (3Y)−0.01 |
| Max drawdown (1Y)−83.5% |
| Max drawdown (3Y)−98.8% |
| Beta (3Y vs SPY)−3.64 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| JANE STREET GROUP, LLC | 54,642 | $202,722 | 1.27% | +408.6% |
| VANGUARD CAPITAL MANAGEMENT LLC | 31,099 | $115,377 | 0.72% | new |
| GEODE CAPITAL MANAGEMENT, LLC | 24,819 | $92,080 | 0.58% | +99.9% |
| Cambridge Investment Research Advisors, Inc. | 20,000 | $74,000 | 0.47% | new |
| VANGUARD FIDUCIARY TRUST CO | 16,205 | $60,121 | 0.38% | new |
| Prospect Financial Services LLC | 13,785 | $51,144 | 0.32% | −30.5% |
| MORGAN STANLEY | 6,500 | $24,115 | 0.15% | +0.0% |
| UBS Group AG | 6,312 | $23,418 | 0.15% | +3634.9% |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total.
| Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|---|---|---|---|---|
| 2026-03-31 | 2026-05-11 | −$0.62 | — | — | — |
| 2025-09-30 | 2025-11-12 | −$1.23 | — | — | — |
| 2025-06-30 | 2025-08-11 | — | — | — | — |
| 2025-03-31 | 2025-05-12 | — | — | — | — |
EPS and revenue as reported in this filer's own XBRL — our extraction of the filings, not a vendor consensus feed, and never a beat/miss claim (we carry no estimates). YoY compares the same fiscal quarter a year earlier. Next report 2026-08-12 is ESTIMATED from filing cadence (median gap 93d) — not company-confirmed.
